May 7, 2024/News Releases

Cleveland Clinic Announces New Leaders to Northeast Ohio Market President and Cleveland Clinic Abu Dhabi CEO

Photo of Cleveland Clinic main campus

Media Contact

Angie Kiska | 216.312.9170

Media Downloads

images: 3

video: 0

audio: 0

text: 0

Content is property of Cleveland Clinic and for news media use only.

Cleveland Clinic has announced new leaders for its Northeast Ohio Market and Cleveland Clinic Abu Dhabi.

These appointments will be effective as follows:

  • On July 1, Donald A. Malone, Jr., M.D., will transition from his role as President of the Northeast Ohio Market, to serve as a senior advisor for capital, space and strategy. He will also continue his clinical practice.
  • On July 1, Jorge A. Guzman, M.D., Chief Executive Officer of Cleveland Clinic Abu Dhabi (CCAD), part of the M42 group, will be returning to the United States to serve as the new President of the Northeast Ohio Market.
  • On June 1, Georges-Pascal Haber, M.D., Ph.D., has been appointed the new Chief Executive Officer of Cleveland Clinic Abu Dhabi.

Dr. Malone began his career as a clinician and researcher. During his 35 years at Cleveland Clinic, he has held numerous leadership positions, including Chair of the Department of Psychiatry and Psychology and President of Lutheran Hospital. Dr. Malone is recognized internationally for his contributions to psychiatric research and innovation.

In his new role, Dr. Guzman will be responsible for overseeing the leadership for main campus, all Ohio regional hospitals, family health centers, ambulatory sites and pharmacy.

Dr. Guzman joined Cleveland Clinic in 2007. Since 2021, he has served as Chief Executive Officer of CCAD. During his tenure as CEO, Cleveland Clinic Abu Dhabi became the only quaternary academic medical center in the UAE. In addition, it was ranked best hospital in the country and the region and one of the top hospitals worldwide over several years.

Prior to this role, Dr. Guzman served as Chief of Staff for five years and Chief Medical Officer in 2017. Before his time in Abu Dhabi, he served as Vice President of Regional Hospital Medical Operations at our main campus. He was the Director of the Medical Intensive Care Unit and Chair of the ICU Operations for Cleveland Clinic Health System, where he coordinated the standards of critical care services and led the development of the ICU telemedicine program (e-hospital).

He received his medical degree from the Universidad Nacional de Córdoba, Argentina, in 1988. After completing his residency in internal medicine and a fellowship in critical care medicine at Hospital Privado de Comunidad, Mar del Plata, Argentina, he completed an additional fellowship in Critical Care Medicine at Wayne State University in Detroit. Dr. Guzman is a fellow of the American College of Critical Care, and a graduate of the Baldwin Wallace University Healthcare MBA program.

Dr. Haber will be leading a workforce of more than 5,300 caregivers at Cleveland Clinic Abu Dhabi, with a focus on strategic growth, and excellence in high acuity care. As part of the M42 group, he will also play a wider role in driving innovation and tech-enabled health solutions in line with the group’s mission to transform the traditional healthcare landscape. He has been with Cleveland Clinic for nearly 20 years, most recently as Chair of the Glickman Urological Institute, Enterprise Chair of Urology, and Professor of Surgery.

As a surgical innovator, he led his teams in performing the first-ever single port laparoscopic donor nephrectomy in Europe and the first robotic kidney transplant in the United Arab Emirates, and multiple firsts at Cleveland Clinic, including robotic intracorporeal urinary diversion, robotic kidney auto transplant and robotic Level 3 IVC thrombectomy.

Dr. Haber received his undergraduate and medical degrees from the Joseph Fourier University in Grenoble, France. He completed residency training at the Lille University Hospital in Lille, France. His doctorate is in biotechnology from the University of Paris XI.

Both Drs. Guzman and Haber will report to CEO and President Tom Mihaljevic, M.D.

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries. Visit us at Follow us at News and resources available at

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

Latest from the Newsroom